Qube Research & Technologies (QRT)
SCPH

Qube Research & Technologies (QRT)’s scPharmaceuticals SCPH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-31,416
Closed -$285K – 2939
2023
Q1 		$285K Buy
31,416
+15,779
+101% +$116K ﹤0.01% 1778
2022
Q4 		$112K Buy
+15,637
New +$95.5K ﹤0.01% 1974

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SCPH Position: Q2 2023 in Review

Qube Research & Technologies (QRT) sold out of scPharmaceuticals (SCPH) in Q2 2023, closing a stake of 31,416 shares — an estimated $285K sold.

Qube Research & Technologies (QRT) first reported a position in SCPH in Q4 2022 and held it in 2 quarters. The position peaked at $285K in Q1 2023. 81 funds tracked by Wall St. Rank hold SCPH as of Q2 2023.

  • Qube Research & Technologies (QRT) reported no remaining scPharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 31,416 scPharmaceuticals shares in Q2 2023, an estimated $285K.
  • Qube Research & Technologies (QRT) first reported a position in scPharmaceuticals in Q4 2022 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s scPharmaceuticals position peaked at $285K in Q1 2023.
  • 81 funds tracked by Wall St. Rank held scPharmaceuticals as of Q2 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.